Skip to content
Screener

Arvinas ARVN Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$3.22M-38.5%
LON
LeonaBio, Inc.LONA
$478K+12.2%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$12.12M+3.0%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$4.63M+13.1%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$99K-28.3%
Immunome logo
ImmunomeIMNM
$152K

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
Net income-$57.6M-169%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Market cap$572.13M+18.3%
Enterprise value$493.43M+30.3%
P/S6.4×+5.1×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0.0×
Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Arvinas’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 5:18 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-033669
(dollars and shares in millions, except per share amounts)March 31,2026December 31,2025
Current liabilities:
Accounts payable and accrued liabilities$62.3$69.5
Deferred revenue51.871.3
Current portion of operating lease liabilities1.81.7
Total current liabilities115.9142.5
Deferred revenue138.2134.3
Long-term debt0.30.4
Operating lease liabilities6.36.8

Item 1. Financial Statements (Unaudited)

FAQ

What is Arvinas's operating lease liabilities (current)?
Arvinas (ARVN) reported operating lease liabilities (current) of $1.8M in Q1 2026.
How has Arvinas's operating lease liabilities (current) changed year-over-year?
Arvinas's operating lease liabilities (current) decreased by 5.3% year-over-year, from $1.9M to $1.8M.
What is the long-term trend for Arvinas's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Arvinas's operating lease liabilities (current) has grown at a 11.2% compound annual growth rate (CAGR), from $1M to $1.7M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Arvinas's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude